Pilot RCT in 100 adults within 48 h of intracerebral haemorrhage: colchicine 0.5 mg daily vs placebo was feasible (8.9 recruits/site/year, 92% 6-month retention), but 27% in each group stopped the drug early; exploratory efficacy and safety endpoints did not differ.
RCTn = 100
Katsanos et al. Colchicine for the Prevention of Vascular Events After an Acute Intracerebral Hemorrhage: A Placebo-Controlled Trial